10mgCOA image placeholder
VP-TSM10
GHRH analogue researched for visceral adipose tissue reduction in metabolic studies.
Synthetic analogue of human GHRH. FDA-approved form (Egrifta) used for HIV-associated lipodystrophy — one of the most clinically validated GH-releasing peptides. Studied for visceral fat and body composition in metabolic research.
Weight management and metabolic research protocols
For research and laboratory purposes only. Not for human use. These statements have not been evaluated by the Therapeutic Goods Administration (TGA). This product is not intended to diagnose, treat, cure, or prevent any disease.